About Agencia Costarricense de Investigaciones Biomédicas (ACIB)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
4
Clinical Trials at Agencia Costarricense de Investigaciones Biomédicas (ACIB)
During the past decade, Agencia Costarricense de Investigaciones Biomédicas (ACIB) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
2009-03-30
2023-12-31
Active, not recruiting
8,670
Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study
2017-11-29
2025-08-01
Enrolling by invitation
28,000
Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study
2018-07-02
2026-02-28
Active, not recruiting
991
Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial
2019-04-01
2023-02-28
Active, not recruiting
1,240
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)"
#1 collaborator was "Bill and Melinda Gates Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Agencia Costarricense de Investigaciones Biomédicas (ACIB)
According to Clinical.Site data, the most researched conditions in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are
"Human Papillomavirus Infection" (3 trials), "Human Papillomavirus-Related Cervical Carcinoma" (3 trials), "Anal Carcinoma" (1 trials), "Cervical Carcinoma" (1 trials) and "Human Papillomavirus-Related Malignant Neoplasm" (1 trials). Many other conditions were trialed in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" in a lesser frequency.
Clinical Trials Intervention Types at Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Most popular intervention types in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are "Other" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Questionnaire Administration" (3 trials), "Recombinant Human Papillomavirus Bivalent Vaccine" (2 trials), "Biospecimen Collection" (1 trials), "Cytology Specimen Collection Procedure" (1 trials) and "Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Agencia Costarricense de Investigaciones Biomédicas (ACIB)
The vast majority of trials in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)" are
4 trials for "Female" genders.
Clinical Trials Status at Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Currently, there are NaN active trials in "Agencia Costarricense de Investigaciones Biomédicas (ACIB)".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were undefined completed trials in Agencia Costarricense de Investigaciones Biomédicas (ACIB),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Agencia Costarricense de Investigaciones Biomédicas (ACIB), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".